When Cactus Communications was founded in 2002, it soon became apparent that the pharmaceutical, medical device, and biotechnology industries required special focus. Cactus Life Sciences was set up to meet the unique needs of pharmaceutical, biotechnology, and medical device companies at both the global and regional levels and help them deconstruct complex medical data and rigorous technical requirements to reach their target audience.
Cactus Life Sciences is a global enterprise with its headquarters in Princeton and offices in Tokyo, Shanghai, Beijing, Mumbai, and Seoul. Our specialist team of medical directors and writers with advanced degrees (MDs, PhDs), industry certifications (CMPP, BELS), and extensive expertise in therapeutic areas helps navigate the complex landscape of biomedical communications, regulatory requirements, and digital media. The scientific team is supported by an experienced account management and project management team that ensures that all strategic communication plans and tactics are delivered on time and within budget. Our strong technology, content, and digital teams are backed by processes and systems that support innovation.
We aspire to be trusted advisors in the life sciences by leveraging our scientific acumen, cutting-edge creative and digital solutions, advanced technology, and transformational delivery models.
We help global and regional teams chalk out publication strategies, develop publication plans with both traditional and digital tactics, and manage all aspects of planning and tactical execution.
We work with MSLs, product teams, and medical teams as well as external stakeholders like HCPs and patients to understand gaps and develop strategic medical communication plans.
We create impactful and engaging communication material that is disseminated across various channels, and help clients keep up with the different ways in which stakeholders seek and access information.
We help communicate complex product knowledge through fair and scientifically balanced medical information letters for patients and healthcare professionals, and create and disseminate medical information in new digital formats.
We ensure the accuracy of medical assets through proofreading and editorial services, reference and fact checking, and technical review.
We integrate scientific writing and regulatory expertise to help medical device companies stay compliant to current regulations.
These specialized services include the creation of HEOR collaterals like GVDs, evidence decks, white papers, and interactive/digital payor content.
We use artificial intelligence (AI), natural language processing (NLP), and machine learning (ML) to increase the efficiency and effectiveness of content creation processes and workflows within the medical communications space.
Cactus Life Sciences has always been thorough…producing work to a high standard and delivering to short timelines. They welcome and take on board feedback to be able to provide the best service to meet our needs. They have a positive attitude and it is always a pleasure to interreact and work with such professional, skilled people. Thank you for making me look good.
Medical Writing Manager,
Global Medical Writing at a US-based global biotechnology company
Cactus Life Sciences has a great team, they deliver really high-quality documents in a short time. New CER projects; remediation of other vendors’ CERS – indicates trust in us.
Director for global regulatory operations at a US-based medical device company
While a thorough QC is required for every document, we recognize that some types are particularly challenging. This requires us to ensure that our QC partner gets all of the information and assistance necessary to tackle some of the more challenging aspects of these documents. Frequently, these documents come to our external QC process with little to no advance notice and require expedited turnarounds. We make every effort to mitigate such situations, however - our team at Cactus Life Sciences has met or exceeded our expectations for timely delivery.
Regulatory Affairs at a Europe-based global pharmaceutical company